2019 AAHKS Annual Meeting

Abstracts Archives

The following abstracts were presented at the podium during the 2019 AAHKS Annual Meeting from November 8-10, 2019 at the Hilton Anatole in Dallas. Download the PDF of the Final Program Book, the Final Schedule and download the final list of disclosures.

AAHKS Awards

The James A. Rand Young Investigator’s Award

Traditional Intravenous Fluid vs. Oral Fluid Administration in Primary Total Knee Arthroplasty: A Randomized Trial
Presenter: Jason M. Jennings, MD
Co-Authors: Mauricio Mejia, MD, Michael A. Williams, MD, Roseann M. Johnson, BS, Charlie C. Yang, MD, Douglas A. Dennis, MD

The Lawrence D. Dorr Surgical Techniques & Technologies Award

Aseptic Reoperations Within One Year of Primary Total Hip Arthroplasty Markedly Increase the Risk of Later Periprosthetic Joint Infection
Presenter: Ashton H. Goldman, MD
Co-Authors: Douglas Osmon, MD, Arlen D. Hanssen, MD, Mark W. Pagnano, MD, Daniel J. Berry, MD, Matthew P. Abdel, MD

The AAHKS Clinical Research Award

No Evidence for Higher Patient-Reported Outcome Scores After Total Hip Arthroplasty with the Direct Anterior Approach at 1.5 Months Postoperatively, and Through a 5-Year Follow-Up
Presenter: Nicholas Sauder, BA
Co-Authors: Veronique Vestergaard, MD, Saira Siddiqui, MPH, Vincent P. Galea, BA, Charles R. Bragdon, PhD, Henrik Malchau, MD, PhD, Karim A. Elsharkawy, MD, James I. Huddleston, MD, Roger H. Emerson, MD

Podium Abstracts in Order of Presentation

  1. No Difference in Survivorship or Functional Outcome Between Surgeon Preference for Computer Assisted Navigation vs. Conventional Instrumentation in 19,221 Total Knee Arthroplasties at 12 Years
    Timothy Roberts, MBChB
  2. Functional Gain and Pain Improvement After Primary Total Knee Replacement Are Influenced by Patient Characteristics and Not Implant Manufacturer
    David C. Ayers, MD
  3. The Cumulative Effect of Depression and Substance Abuse on Postoperative Complications After Primary Total Knee Arthroplasty
    Peter A. Gold, MD
  4. Preoperative Behavioral Pain Management Strategies in Total Joint Arthroplasty: A Prospective Randomized Controlled Trial Comparing Mindfulness, Hypnosis and Cognitive-Behavioral Psychoeducation
    Jeremy M. Gilliland, MD
  5. The Effect of the IPACK Block on Pain Following Primary TKA: A Double Blinded, Prospective, Randomized Trial
    George F. Chimento, MD
  6. Intraoperative Surgeon Administered Adductor Canal Blockade Is Not Inferior to Anesthesiologist Administered Adductor Canal Blockade: A Prospective Randomized Trial
    Asim Makhdom, MD, MSc, FRCSC
  7. Quicker and More Predictable Return of Motor Function and Ambulation After Mepivacaine vs. Bupivacaine Spinal: A Double Blind RCT in Primary TKA and THA
    Cody C. Wyles, MD
  8. The Use of Tourniquet Does Not Negatively Influence Outcomes in Total Knee Arthroplasty: A Randomized Controlled Trial
    Ran Schwarzkopf, MD
  9. Pain Control After Total Hip Arthroplasty: A Randomized Trial Determining Efficacy of Fascia Iliaca Compartment Blocks in the Immediate Postoperative Period
    Kamil Bober, MD
  10. Topical Tranexamic Acid Increases Early Postoperative Pain After Total Hip Arthroplasty
    R. Michael Meneghini, MD
  11. Risk of Dislocation by Surgical Approach Following Modern Primary Total Hip Arthroplasty
    Michael J. Taunton, MD
  12. The Majority of Total Hip Arthroplasty Patients with a Stiff Spine Do Not Have an Instrumented Fusion
    Douglas A. Dennis, MD
  13. The Effect of Preoperative Anemia on Complications Following Total Hip Arthroplasty
    Matthew J. Grosso, MD
  14. Does Femoral Morphology Predict the Risk of Periprosthetic Fracture After Cementless Total Hip Arthroplasty?
    Denis Nam, MD, MSc
  15. Does Femoral Component Cementation Affect Costs or Clinical Outcomes After Hip Arthroplasty in Medicare Patients?
    Matthew S. Hepinstall, MD
  16. Removal of Total Knee Arthroplasty from the Inpatient Only List Adversely Affects Bundled Payment Programs
    Michael Yayac, MD
  17. The Clinical and Financial Consequences of the Centers for Medicare and Medicaid Services’ Two-Midnight Rule in Total Joint Arthroplasty
    Adam J. Schwartz, MD
  18. Surgeon Reimbursement Unchanged as Hospital Charges and Reimbursements Increase for Total Hip Arthroplasty
    Dennis Q. Chen, MD
  19. Hospital Total Joint Arthroplasty Case-Mix Burden and Patient Flows in the Era of Payment Reform: Impact on Resource Utilization Among New York State Hospitals
    Calin S. Moucha, MD
  20. Are We Treating Similar Patients? Hospital Volume and the Difference in Patient Populations for Total Knee Arthroplasty
    Robert M. Molloy, MD
  21. Reviews of Orthopedic Surgeons on Physician Rating Websites: Analysis of 11535 Reviews
    Atul F. Kamath, MD
  22. Body Mass Index Is a Better Predictor of Periprosthetic Joint Infection Risk than Local Measures of Adipose Tissue Following Total Knee Arthroplasty
    Simon W. Young, MBChB, FRACS, MD
  23. Fate of the Morbidly Obese Patient Who Is Denied Total Joint Arthroplasty
    Joshua A. Shapiro, MD
  24. Primary Total Knee Arthroplasty Performed Using High-Viscosity Cement Is Associated with Higher Odds of Revision for Aseptic Loosening
    Leonard T. Buller, MD
  25. Stiffness After Total Knee Arthroplasty: Is It a Result of Spinal Deformity?
    Jonathan M. Vigdorchik, MD
  26. Identification of Clinical and Biological Risk Factors for Postoperative Stiffness After Total Knee Arthroplasty for Osteoarthritis
    Meghan Kirksey, MD, PhD
  27. Manipulation Under Anesthesia After Total Knee Arthroplasty: Who Still Requires a Revision?
    David P. Brigati, MD
  28. Polymerase Chain Reaction Multiplex Provides Minimal Utility in Periprosthetic Joint Infection Diagnosis
    Beau J. Kildow, MD
  29. Prospective, Multicenter, Adjudicator-Blinded Clinical Trial of the Alpha-Defensin Lateral Flow Test for Periprosthetic Infection
    Carl A. Deirmengian, MD
  30. Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Periprosthetic Joint Infection in Total Knee Arthroplasty Patients
    Carlos A. Higuera, MD
  31. Reinfection or Persistence of Periprosthetic Joint Infection? Next Generation Sequencing Reveals New Findings
    Karan Goswami, MD
  32. Antibiotic Susceptibility of Organisms Recovered in Culture from Patients with Acute Prosthetic Joint Infection Following Primary Total Knee Arthroplasty
    Charles M. Lawrie, MD
  33. Cutibacterium acnes Colonization: Implications for Total Hip Arthroplasty
    Jacob M. Elkins, MD, PhD
  34. A Multi-Center Randomized Clinical Trial of Tranexamic Acid in Revision Total Hip Arthroplasty: Does the Dosing Regimen Matter?
    Robert A. Sershon, MD
  35. Is There a Benefit to Modularity for Femoral Revisions When Using a Splined, Tapered Titanium Stem?
    Matthew R. Cohn, MD
  36. Projections and Epidemiology of Revision Hip and Knee Arthroplasty in The United States to 2030
    Andrew M. Schwartz, MD
  37. Outcome of Re-Revision Surgery for Adverse Local Tissue Reaction in Metal-on-Polyethylene and Metal-on-Metal Total Hip Arthroplasty
    Young-Min Kwon, MD, PhD
  38. Patients Following Revision Total Hip Arthroplasty with Modular Dual Mobility Components Are at Risk of Increased Serum Metal Ion Levels
    Roberto Civinini, MD
  39. Serum Metal Ion Levels following Total Hip Arthroplasty: A Comparison Between Monoblock and Modular Dual Mobility Components
    Ivan De Martino, MD
  40. What Is the Impact of PAO Surgery on Patient Function and Activity Levels?
    Jeff R. Petrie, MD
  41. Surgical Treatment of Femoroacetabular Impingement: A Minimum 10-Year Outcome and Risk Factors for Failure
    Hamed Vahedi, MD
  42. Hip Arthroscopy for Patients with Persistent Pain following Periacetabular Osteotomy: No Significant Changes in Pre- and Postoperative Patient Reported Outcomes
    Mario Hevesi, MD
  43. Hemiarthroplasty vs. Total Hip Arthroplasty for Femoral Neck Fractures: 2010-2017 Trends in Complication Rates
    Juan C. Suarez, MD
  44. Patient and Surgeon Satisfaction with and Utility of Routine Follow-Up at One Year After Primary Total Hip and Total Knee Arthroplasty
    Ryan M. Nunley, MD
  45. Can an Outpatient Risk Assessment Tool Predict Who Needs Postoperative Hemoglobin Monitoring?
    John R. Martin, MD
  46. Opioid Use After Discharge Following Primary Unilateral Total Knee Arthroplasty: How Much Are We Over-Prescribing?
    Travis SScudday, MD
  47. Education Increases Disposal of Unused Opioids After Total Joint Arthroplasty: A Cluster Randomized Trial
    Charles P. Hannon, MD
  48. Is Preoperative Tramadol a Safe Alternative to Opioids in Total Knee Arthroplasty?
    David E. DeMik, MD
  49. The Effects of Opioid Use on Thromboembolic Complications, Readmission Rates and 90-Day Episode of Care Costs
    Nipun Sodhi, MD
  50. Use of Tetrahydrocannabinol and Cannabidiol Products in the Perioperative Period Around Primary Unilateral Total Knee Arthroplasty and the Impact on Opioid Consumption
    Robert P. Runner, MD
  51. Does Intermittent Catheterization Compared to Indwelling Catheterization Decrease the Risk of Periprosthetic Joint Infection Following Total Knee Arthroplasty?
    Luke Garbarino, MD
  52. Dilute Povidone-Iodine Solution Prevents Intraoperative Contamination of Sterile Water Basins during Total Joint Arthroplasty
    J. Luke Galloway, BA
  53. A Randomized Clinical Trial of Articulating and Static Spacers in the Management of Chronic Periprosthetic Knee Infection
    Cindy R. Nahhas, BS
  54. Isolated Tibial Insert Exchange in Aseptic Revision TKA: Reliable & Durable for Wear; Less So for Instability, Insert Fracture/Dissociation, or Stiffness
    Matthew W. Tetreault, MD
  55. Administration of Tranexamic Acid Improves Long-Term Outcomes in Total Knee Arthroplasty
    Kenneth L. Urish, MD, PhD
  56. Fixed-Bearing Medial Unicondylar Knee Arthroplasty – Slight Varus, Just Right! 
    Sean E. Slaven, MD

Symposium Abstracts in Order of Presentation

  1. Multimodal Anesthesia and Analgesia in Total Joint Arthroplasty: Where Do We Stand in 2019? A Collaborative Clinical Practice Guideline
    Moderator: William G. Hamilton, MD
    Panelists: Yale A. Fillingham, MD, Denis Nam, MD, MSc, James A. Browne, MD, William G. Hamilton, MD
  2. Simplifying the Hip-Spine Relationship for Total Hip Arthroplasty
    Moderator: Jonathan M. Vigdorchik, MD
    Panelists: Michael P. Bolognesi, MD, Lawrence D. Dorr, MD, Douglas A. Dennis, MD, Jonathan M. Vigdorchik, MD
  3. Total Knee Arthroplasty Removal from the Medicare Inpatient-Only (IPO) List: Implications for Surgeons, Patients, and Hospitals
    Moderator: Richard Iorio, MD
    Panelists: Derek A. Haas, MBA, C. Lowry Barnes, MD, Charles M. Davis, MD, PhD
  4. The Current State of Practice Patterns of AAHKS Members
    Moderator: Jay R. Lieberman, MD
  5. The Psychology of Total Joint Arthroplasty: Can We Modify Outcomes?
    Moderator: Bryan D. Springer, MD
    Panelists: Padma Gulur, MD, Wayne Sotile, PhD
  6. Tips and Tricks to Save You During Revision TKAs:  Video-Based Demonstrations
    Moderator: Matthew P. Abdel, MD
    Panelists: Daniel J. Berry, MD, Craig J. Della Valle, MD, R. Michael Meneghini, MD
  7. Periprosthetic Infection: A Practical Case-Based Approach
    Moderator: Fares S. Haddad, MD, FRCS
    Panelists: Thomas K. FehringMD, Michael H. Huo, MD, Thorsten M. Seyler, MD, PhD
  8. Adverse Local Tissue Reactions in Total Hip Arthroplasty: Who, When and How to Revise
    ModeratorYoung-Min Kwon, MD, PhD
    Panelists: Joshua J. Jacobs, MD, Michael J. Taunton, MD, Douglas E. Padgett, MD, Adolph V. Lombardi, Jr., MD, FACS
Close Bitnami banner